The best way to inject semaglutide: a practical technique guide

Picture this: pen in hand, you're not quite sure what comes next

You've taken your pen out of the fridge, let it sit at room temperature for about half an hour, and now you're standing in the bathroom wondering whether you're doing this right. That moment of hesitation is entirely normal. A question our prescribers hear most weeks is some version of: "I've watched the video, but I still want someone to walk me through it." So here's the walk-through.

Wash your hands thoroughly first. Then clean the chosen skin area with an alcohol swab and let it dry completely before injecting — wet skin can sting more and the alcohol may affect the injection site if it hasn't evaporated. Medical-grade alcohol swabs are all you need here; there's no special preparation beyond that.

Attach a fresh needle to the pen, remove both needle caps, and check the pen window shows the correct dose setting. Press the pen flush against the skin, no need to pinch the skin unless you are very lean; the fatty tissue in the recommended sites is usually sufficient. Press the injection button firmly and hold it down. Count to ten slowly. That wait is not optional: it is what keeps the full dose inside you rather than on your skin when you withdraw the pen. Lift the pen straight away once the ten seconds are up. You may see a tiny drop of fluid at the site; that's normal. Apply light pressure with a clean fingertip if needed, but do not rub.

For a fuller visual walkthrough of the injection sequence, the complete semaglutide injection guide covers each step in detail.

Where on your body the injection actually goes, and why rotation is not optional

The three licensed sites for subcutaneous semaglutide injection are the abdomen (at least a couple of centimetres away from the navel), the front or outer thigh, and the outer upper arm. Each delivers the medicine reliably. Choosing between these sites often comes down to personal preference and ease of access, the abdomen is the most commonly used, partly because it's easiest to see and reach.

What matters as much as where you inject is that you don't return to exactly the same spot every week. Repeated injection into one small area can cause lipohypertrophy, a build-up of fatty tissue under the skin that looks and feels lumpy, and which can affect how the medicine is absorbed. Rotation prevents this. A practical approach is to think of each site as a clock face and move around it week by week, staying within the licensed area but never landing on last week's exact spot.

If you want a more detailed breakdown of each anatomical location and how to find the right spot within it, the guide to the best area for semaglutide injections goes into that level of specificity. The NHS England guidance on weight-management injections also briefly covers site rotation and skin care.

One practical note: avoid injecting into skin that is bruised, tender, scarred, or affected by a rash. The medicine is still absorbed in healthy tissue nearby; there is no need to use a compromised area.

Timing, storage, and the things that trip people up most

Semaglutide is a once-weekly injection, taken on the same day each week. You can take it at any time of day, with or without food, unlike the oral tablet form of semaglutide, the injection has no fasting requirement. Many people find it easiest to pick a consistent day and anchor it to something routine, like the start of the week. The best time of day to inject semaglutide is whichever time you're most reliably at home with your pen accessible.

Storage is a common source of confusion. Semaglutide pens must be kept refrigerated at 2–8°C when not in use. There is a limited window during which the pen can be kept at room temperature, the exact duration is specified in your Patient Information Leaflet, and you should follow that figure rather than any general estimate you find online, because it is specific to your product. Do not freeze the pen, and keep it away from direct light. For guidance on how long your pen remains usable after opening, this page on fridge storage timelines is worth reading alongside your leaflet.

Used needles should go into a proper sharps container immediately after each injection, never into household rubbish or a recycling bin. A one-litre sharps container is the standard for home use and can be disposed of through your local pharmacy or council-run collection point. Needle disposal is a legal requirement, not a suggestion.

If you are considering semaglutide for weight management, it is prescribed as Wegovy, and if you'd like to understand the broader treatment, our Wegovy overview covers how the medicine works, what the clinical evidence shows, and what to expect from treatment.

The injection went fine, but what if something feels off?

Some mild reaction at the injection site is common when starting treatment: a small amount of redness, itching, or bruising is not unusual and typically fades within a day. The NHS semaglutide page lists these as recognised side effects rather than causes for alarm. Rotating your sites consistently, as described above, reduces the likelihood of ongoing local reactions.

There are signs, however, that mean you should stop and seek medical advice rather than continue. A hard lump that persists for several weeks at an injection site, a rash that spreads beyond the injection area, or any sign of an allergic reaction (swelling of the face or throat, difficulty breathing, rapid heartbeat) requires prompt attention. Do not attempt to manage these at home.

Beyond injection-site effects, semaglutide's most common side effects are gastrointestinal: nausea, constipation, loose stools, and indigestion are all reported, most often in the early weeks of treatment or after a dose increase. These are not a technique problem; they reflect the medicine's mechanism. If you experience severe, persistent stomach pain that radiates toward the back, seek urgent medical help. The MHRA has highlighted acute pancreatitis as a serious but infrequent risk with GLP-1 medicines.

Any suspected side effect can be reported directly to the MHRA using the Yellow Card scheme. It is open to patients as well as healthcare professionals, and reports genuinely contribute to medicine safety monitoring in the UK.